| MCap |
Div. |
KGV |
Name (Symbol) |
Kursentwicklung 1J, 3J, 5J, 10J |
Chart 10J |
|
|
| 24Mrd. |
– |
– |
 Illumina, Inc. (ILMN) |
+37 %
|
-63 %
|
-49 %
|
-20 %
|
 |
| 15Mrd. |
– |
– |
Natera, Inc. (NTRA) |
+206 %
|
+9 %
|
+224 %
|
–
|
 |
| 6Mrd. |
– |
– |
Ionis Pharmaceuticals, Inc. (IONS) |
-11 %
|
+18 %
|
-29 %
|
-15 %
|
 |
| 6Mrd. |
– |
– |
Blueprint Medicines Corporation (BPMC) |
+53 %
|
-18 %
|
+35 %
|
–
|
 |
| 5Mrd. |
– |
45 |
Krystal Biotech, Inc. (KRYS) |
+48 %
|
+236 %
|
+304 %
|
–
|
 |
| 4Mrd. |
– |
– |
 CRISPR Therapeutics AG (CRSP) |
+10 %
|
-47 %
|
+4 %
|
–
|
 |
| 3Mrd. |
– |
– |
 GENSCRIPT BIO (1548.HK) |
-49 %
|
-60 %
|
-42 %
|
–
|
 |
| 2Mrd. |
– |
– |
GeneDx Holdings Corp. (WGS) |
+4125 %
|
-71 %
|
–
|
–
|
 |
| 2Mrd. |
– |
– |
10x Genomics, Inc. (TXG) |
-55 %
|
-90 %
|
-72 %
|
–
|
 |
| 2Mrd. |
– |
– |
Beam Therapeutics Inc. (BEAM) |
+7 %
|
-76 %
|
–
|
–
|
 |
| 2Mrd. |
– |
– |
NeoGenomics, Inc. (NEO) |
-3 %
|
-70 %
|
-40 %
|
+202 %
|
 |
| 2Mrd. |
1.5 |
175 |
 Genus plc (GNS.L) |
-9 %
|
-61 %
|
-26 %
|
+88 %
|
 |
| 2Mrd. |
– |
– |
Myriad Genetics, Inc. (MYGN) |
+13 %
|
-42 %
|
-49 %
|
-51 %
|
 |
| 2Mrd. |
– |
– |
Intellia Therapeutics, Inc. (NTLA) |
-44 %
|
-89 %
|
+16 %
|
–
|
 |
| 665Mio. |
– |
– |
Pacific Biosciences of California,… (PACB) |
-63 %
|
-91 %
|
-51 %
|
-63 %
|
 |
| 655Mio. |
– |
– |
Fulgent Genetics, Inc. (FLGT) |
-9 %
|
-75 %
|
+130 %
|
–
|
 |
| 599Mio. |
– |
– |
Neurogene Inc. (NGNE) |
+239 %
|
-69 %
|
-25 %
|
-66 %
|
 |
| 580Mio. |
– |
– |
Anavex Life Sciences Corp. (AVXL) |
+20 %
|
-68 %
|
+148 %
|
+849 %
|
 |
| 541Mio. |
– |
– |
Korro Bio, Inc. (KRRO) |
+311 %
|
-83 %
|
-93 %
|
–
|
 |
| 502Mio. |
– |
– |
Verve Therapeutics, Inc. (VERV) |
-57 %
|
-89 %
|
–
|
–
|
 |
| 484Mio. |
– |
– |
Prime Medicine, Inc. (PRME) |
-39 %
|
–
|
–
|
–
|
 |
| 448Mio. |
– |
– |
MeiraGTx Holdings plc (MGTX) |
+16 %
|
-71 %
|
-61 %
|
–
|
 |
| 431Mio. |
– |
– |
Ginkgo Bioworks Holdings, Inc. (DNA) |
-87 %
|
-99 %
|
–
|
–
|
 |
| 393Mio. |
– |
– |
 enGene Holdings Inc. (ENGN) |
-53 %
|
–
|
–
|
–
|
 |
| 391Mio. |
– |
– |
Sangamo Therapeutics, Inc. (SGMO) |
+309 %
|
-79 %
|
-79 %
|
-84 %
|
 |
| 382Mio. |
– |
26 |
Voyager Therapeutics, Inc. (VYGR) |
+9 %
|
+80 %
|
-53 %
|
–
|
 |
| 336Mio. |
– |
– |
Personalis, Inc. (PSNL) |
+339 %
|
-75 %
|
-55 %
|
–
|
 |
| 314Mio. |
– |
– |
Taysha Gene Therapies, Inc. (TSHA) |
-36 %
|
-91 %
|
–
|
–
|
 |
| 285Mio. |
– |
– |
 uniQure N.V. (QURE) |
+2 %
|
-83 %
|
-88 %
|
-44 %
|
 |
| 240Mio. |
– |
– |
Editas Medicine, Inc. (EDIT) |
-59 %
|
-92 %
|
-86 %
|
–
|
 |
| 240Mio. |
– |
– |
Poseida Therapeutics, Inc. (PSTX) |
+13 %
|
-62 %
|
–
|
–
|
 |
| 216Mio. |
– |
– |
Benitec Biopharma Inc. (BNTC) |
+202 %
|
-83 %
|
-93 %
|
-100 %
|
 |
| 154Mio. |
– |
– |
Adverum Biotechnologies, Inc. (ADVM) |
-24 %
|
-68 %
|
-90 %
|
-98 %
|
 |
| 147Mio. |
– |
– |
Generation Bio Co. (GBIO) |
+121 %
|
-90 %
|
–
|
–
|
 |
| 90Mio. |
– |
– |
bluebird bio, Inc. (BLUE) |
-85 %
|
-97 %
|
-99 %
|
-98 %
|
 |
| 79Mio. |
– |
– |
Metagenomi, Inc. (MGX) |
–
|
–
|
–
|
–
|
 |
| 65Mio. |
– |
35 |
Precision BioSciences, Inc. (DTIL) |
-25 %
|
-97 %
|
-95 %
|
–
|
 |
| 56Mio. |
– |
– |
 Prenetics Global Limited (PRE) |
-4 %
|
-96 %
|
–
|
–
|
 |
| 41Mio. |
– |
– |
ProPhase Labs, Inc. (PRPH) |
-53 %
|
-61 %
|
+57 %
|
+215 %
|
 |
| 39Mio. |
– |
– |
Passage Bio, Inc. (PASG) |
-7 %
|
-93 %
|
–
|
–
|
 |
| 34Mio. |
– |
– |
Singular Genomics Systems, Inc. (OMIC) |
+32 %
|
-97 %
|
–
|
–
|
 |
| 24Mio. |
– |
0 |
Bionano Genomics, Inc. (BNGO) |
-81 %
|
-100 %
|
-97 %
|
–
|
 |
| 7Mio. |
– |
– |
 BioNexus Gene Lab Corp. (BGLC) |
+0 %
|
-81 %
|
–
|
–
|
 |
| 5Mio. |
– |
– |
NanoString Technologies, Inc. (NSTG) |
-98 %
|
-100 %
|
-100 %
|
-100 %
|
 |
| 2Mio. |
– |
– |
Telesis Bio, Inc. (TBIO) |
-90 %
|
-99 %
|
–
|
–
|
 |
|
|
